The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
LDN Social Media
Get connected with us on social networks
Successful treatment of postural orthostatic tachycardia and mast cell activation syndromes using naltrexone, immunoglobulin and antibiotic treatment
BMJ Case Reports
January 2018
https://casereports.bmj.com/content/2018/bcr-2017-221405
Erythromelalgia in a Patient with Mast Cell Activation Syndrome: Response to Low Dose Naltrexone
Skin
08 May 2019
https://jofskin.org/index.php/skin/article/view/722
Erythromelalgia is a rare condition that may be associated with a variety of underlying conditions and is often refractory to therapy. We report a case of a patient with mast cell activation syndrome who developed erythromelalgia and responded to low dose naltrexone.
Leonard Weinstock, MD - POTS and Mast Cell Activation Syndromes (2017 Conference) (LDN, low dose naltrexone)
Dr Leonard Weinstock is from St Louis in Missouri and helps patients with GI Issues and other autoimmune conditions.
Gastroenterologist Dr Leonard Weinstock - 11th March 2020 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Linda Elsegood: Today, I'd like to welcome my guest, Dr Leonard Weinstock. He's a gastroenterologist from Missouri. Thank you for joining us today.
Dr Leonard Weinstock: You’re welcome.